Artemis Medicare Services Ltd

Artemis Medicare Services Earnings Call Transcript: Key Takeaways

Artemis reports strong growth led by Gurgaon's record EBITDA and new Raipur operations. Aggressive expansion plans aim for 2,000 beds within five years despite regulatory drug pricing concerns.

Artemis Medicare Services Other Announcement

Artemis Medicare filed CARE Ratings' quarterly monitoring report on its Rs.330 crore preferential issue. It reports no deviation, with proceeds used as per the disclosed objects.

Artemis Medicare Services Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue INR 31,104 Lacs (+13.2% YoY); adj. EBITDA INR 7,150 Lacs (+22.7%, 23.3% margin); PAT INR 3,110 Lacs (+3.7%). Raipur ramp-up dilutes reported margins.

Artemis Medicare Services Results Update

Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.

Artemis Medicare Services Q2 FY27 Results: Net Profit ₹31.1 Cr, Up 3.7% YoY

Artemis Medicare Services Ltd reported revenue from operations of ₹311 Cr (+13.2% YoY) and net profit of ₹31.1 Cr (+3.7% YoY) for Q2 FY27.

Key figure

Net profit ₹31.1 Cr · +3.7% YoY

Artemis Medicare Services Board Meeting Date

Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.